Dolutegravir (DTG), sold under the brand name Tivicay, is an antiretroviral medication used, together with other medication, to treat HIV/AIDS. It may...
19 KB (1,564 words) - 09:00, 30 September 2024
Dolutegravir/lamivudine/tenofovir (DTG/3TC/TDF) is a fixed-dose combination antiretroviral medication used to treat HIV/AIDS. It is a combination of dolutegravir...
9 KB (555 words) - 04:24, 2 October 2023
Dolutegravir/lamivudine, sold under the brand name Dovato, is a fixed-dose combination antiretroviral medication for the treatment of HIV/AIDS. each pill...
9 KB (612 words) - 06:28, 29 May 2024
Abacavir/dolutegravir/lamivudine, sold under the brand name Triumeq among others, is a fixed-dose combination antiretroviral medication for the treatment...
14 KB (1,267 words) - 05:54, 6 August 2024
Dolutegravir/rilpivirine, sold under the brand name Juluca, is a fixed-dose combination antiretroviral medication for the treatment of HIV/AIDS. It contains...
8 KB (432 words) - 05:30, 6 July 2024
name Combivir) abacavir/dolutegravir/lamivudine (brand name Triumeq) dolutegravir/lamivudine (brand name Dovato) dolutegravir/rilpivirine (brand name...
8 KB (624 words) - 01:32, 26 July 2024
(INSTI) class that was structurally derived from an earlier compound dolutegravir by scientists at Gilead Sciences. In vitro and clinical results were...
13 KB (839 words) - 04:02, 28 February 2024
July 2018, and in Australia in November 2019. Dolutegravir/emtricitabine/tenofovir alafenamide. Dolutegravir/lamivudine/tenofovir alafenamide. Gilead announced...
29 KB (1,823 words) - 05:48, 26 July 2024
J05AR25 Lamivudine and dolutegravir J05AR26 Darunavir and ritonavir J05AR27 Lamivudine, tenofovir disoproxil and dolutegravir J05AR28 Stavudine and lamivudine...
6 KB (538 words) - 04:59, 18 December 2023
typically used in combination with other antiretrovirals such as zidovudine, dolutegravir, and abacavir. Lamivudine may be included as part of post-exposure prevention...
16 KB (1,566 words) - 08:15, 1 May 2024
received regulatory approvals since Viatris was established include: Dolutegravir: In December 2020, received FDA approval to treat children with HIV/AIDS...
23 KB (1,914 words) - 03:15, 25 October 2024
alafenamide° Dolutegravir/emtricitabine/tenofovir alafenamide Dolutegravir/lamivudine° Dolutegravir/lamivudine/tenofovir alafenamide° Dolutegravir/lamivudine/tenofovir...
15 KB (1,230 words) - 02:38, 16 July 2024
ritonavir) Ritonavir Dolutegravir Raltegravir Abacavir/lamivudine (abacavir + lamivudine) Dolutegravir/lamivudine/tenofovir (dolutegravir + lamivudine + tenofovir)...
67 KB (4,822 words) - 18:15, 10 November 2024
(D-lactic acidosis) Nucleoside reverse-transcriptase inhibitors Abacavir/dolutegravir/lamivudine Emtricitabine/tenofovir Potassium cyanide (cyanide poisoning)...
25 KB (2,823 words) - 04:38, 11 October 2024
alafenamide° Dolutegravir/emtricitabine/tenofovir alafenamide Dolutegravir/lamivudine° Dolutegravir/lamivudine/tenofovir alafenamide° Dolutegravir/lamivudine/tenofovir...
28 KB (2,975 words) - 02:18, 11 August 2024
integrase inhibitor with a carbamoyl pyridone structure similar to that of dolutegravir. In December 2021, the U.S. Food and Drug Administration approved cabotegravir...
25 KB (1,919 words) - 05:11, 16 July 2024
Examples of integrase inhibitors include raltegravir, elvitegravir, and dolutegravir. Once a virus genome becomes operational in a host cell, it then generates...
55 KB (6,733 words) - 21:23, 24 October 2024
Abacavir Amprenavir Atazanavir Darunavir Delavirdine Didanosine (ddI) Dolutegravir Efavirenz Enfuvirtide Stavudine (d4T) Etravirine Fosamprenavir Indinavir...
26 KB (1,722 words) - 09:50, 2 November 2024
generally does not increase risk of birth defects with exception of dolutegravir, which is not recommended during first trimester of pregnancy only due...
29 KB (2,369 words) - 19:02, 30 October 2024
HIV Adenosine analogue RTI Docosanol Herpes Simplex Entry inhibitor Dolutegravir HIV Integrase inhibitor Doravirine (Pifeltro) HIV NNRTI Edoxudine Herpes...
13 KB (513 words) - 14:31, 4 May 2024
license for dolutegravir, an integrase inhibitor then in clinical development. In 2014, this license was extended to include dolutegravir and adults with...
136 KB (12,275 words) - 14:36, 8 November 2024
other HIV medications, such as abacavir/lamivudine/zidovudine, abacavir/dolutegravir/lamivudine, and abacavir/lamivudine. The combination abacavir/lamivudine...
33 KB (2,771 words) - 17:59, 28 July 2024
Qcil currently produces TLD (a combination of tenofovir, lamivudine and dolutegravir), the latest first-line treatment used to treat and prevent HIV/AIDS...
11 KB (867 words) - 15:38, 26 October 2024
alafenamide° Dolutegravir/emtricitabine/tenofovir alafenamide Dolutegravir/lamivudine° Dolutegravir/lamivudine/tenofovir alafenamide° Dolutegravir/lamivudine/tenofovir...
3 KB (338 words) - 13:45, 27 July 2023
four other clinically approved integrase inhibitors are elvitegravir, dolutegravir, bictegravir, and cabotegravir. Protease inhibitors block the viral protease...
133 KB (15,784 words) - 05:42, 17 September 2024
Amsterdam on 21 to 27 July 2018. Primary topics of note included: Use of dolutegravir as an antiretroviral medication was reported to result in increased rates...
14 KB (1,399 words) - 12:43, 14 August 2024
Genvoya (Elvitegravir/cobicistat/emtricitabine/tenofovir alafenamide). Dolutegravir (Tivicay), licensed by ViiV Healthcare, was approved for use in the US...
6 KB (622 words) - 17:42, 23 December 2023
the largest HiPotent API capacities in India The company also makes Dolutegravir/lamivudine/tenofovir, a medication for HIV/AIDS, and hydroxychloroquine...
11 KB (773 words) - 17:56, 23 May 2024
example, polymorphonuclear [PMN], bronchioloalveolar carcinoma [BAC], dolutegravir [DTG]), there is no law preventing the letters of the acronym from representing...
6 KB (854 words) - 04:14, 25 July 2024
25% drop in the cost of tenofovir disoproxil fumarate, lamivudine, and dolutegravir (TLD), the first-line treatment for HIV. A new mosquito net, treated...
15 KB (1,541 words) - 14:33, 27 October 2024